` AMIORG (Ami Organics Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

AMIORG
vs
BSE Sensex 30

Over the past 12 months, AMIORG has underperformed BSE Sensex 30, delivering a return of -12% compared to the BSE Sensex 30's 7% growth.

Stocks Performance
AMIORG vs BSE Sensex 30

Loading
AMIORG
BSE Sensex 30
Add Stock

Performance Gap
AMIORG vs BSE Sensex 30

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
AMIORG vs BSE Sensex 30

Loading
AMIORG
BSE Sensex 30
Add Stock

Competitors Performance
Ami Organics Ltd vs Peers

BSE Sensex 30
AMIORG
LLY
JNJ
NOVO B
ROG
Add Stock

Ami Organics Ltd
Glance View

Market Cap
43.8B INR
Industry
Pharmaceuticals

Ami Organics Ltd. engages in the development and commercialization of pharmaceutical intermediate products. The company is headquartered in Surat, Gujarat and currently employs 561 full-time employees. The company went IPO on 2021-09-14. These specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). The company manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. The company has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The firm supplies its products to more than 150 customers directly in India.

AMIORG Intrinsic Value
HIDDEN
Show
Back to Top